Arexvy powder and suspension for suspension for injection

Company:
GlaxoSmithKline (Ireland) Ltd
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/23/1740/001

RSVPreF31 antigen2,3 120 micrograms

J07BX05

Powder and suspension for suspension for injection

EU/1/23/1740/002

RSVPreF31 antigen2,3 120 micrograms

J07BX05

Powder and suspension for suspension for injection

Address: